| Typicality: | 0.528 |
| Saliency: | 0.271 |
| to document their efficacy | 8 | purpose |
| as with all medical products | 5 | manner |
| for 10 years | 2 | temporal |
| vaccine → go through → rigorous testing | 7 |
| vaccine → undergo → extensive testing | 6 |
| vaccine → undergo → rigorous testing | 5 |
| vaccine → undergo → testing | 4 |
| negative | neutral | positive |
| 0.162 | 0.694 | 0.144 |
| Raw frequency | 22 |
| Normalized frequency | 0.271 |
| Modifier score | 1.000 |
| Perplexity | 47.082 |